Vascular Access and Infused Fluids for Pediatric CRRT

Slides:



Advertisements
Similar presentations
Vascular Access The Alpha and Omega of CRRT
Advertisements

Renal replacement (supportive) therapy in infants
Neonatal and Infant CRRT
Norma J Maxvold Pediatric Critical Care
Acute Renal Replacement Therapy for the Infant Dr.Fahad Gadi, MD Pediatrics Demonstrator King Abdulaziz University Rabigh Medical School.
Acute Renal Replacement Therapy for the Infant Dr.Fahad Gadi, MD Pediatrics Demonstrator King Abdulaziz University Rabigh Medical School.
Pediatric CRRT: Terminology and Physiology
So how do I dose this drug “X” Timothy E Bunchman
Renal Replacement Therapy (RRT)
Dialysis Allam Rizqallah The Palestinian Kidney Transplant Center S.A.H1/2/2005.
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.
CRRT solutions Benan Bayrakci, 2014.
A E UROPEAN R ENAL B EST P RACTICE (ERBP) POSITION STATEMENT ON THE K IDNEY D ISEASE I MPROVING G LOBAL O UTCOMES (KDIGO) C LINICAL P RACTICE G UIDELINES.
Pediatric CRRT: Dialysis and Replacement Solutions William E. Smoyer, M.D. Pediatric Nephrology University of Michigan.
Dialysis and Replacement Solutions for CRRT
Dr Umut Selda Bayrakçı Yıldırım Beyazıt University, Dept of Pediatric Nephrology, Ankara, Turkey * Basics of CRRT Terminology.
Access n If you don’t have it you might as well go home. n This is the most important aspect of CRRT therapy. n Adequacy. n Filter life. n Increased blood.
Troubleshooting Issues in CVVH Timothy L. Kudelka RN, BSN Pediatric Dialysis Program C.S. Mott Children’s Hospital University of Michigan.
Zuragen® Lock (an investigational device)
Matthew L. Paden, MD Division of Pediatric Critical Care
Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his.
Acute Renal Replacement Therapy for the Infant Jordan M. Symons, MD University of Washington School of Medicine Children’s Hospital & Regional Medical.
Dialysis and Replacement Solutions for Pediatric CRRT
ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital.
Vascular access The KidneyCare Audit. The challenge of vascular access – Renal National Service Framework Standard 3 “All children, young people and adults.
Fluid Resuscitation in the ER
Principles and Techniques of Dialysis. Introduction 2 basic techniques – haemo or peritoneal Several refinements within these Haemo –Dialysis –Filtration.
What form of anticoagulation is the “best” Or why is Citrate better then Heparin or Prostacyclin.
Anticoagulation in CRRT
Access in Pediatric CRRT
PCRRT PRESCRIPTIONS in ARF Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
Renal Replacement Therapy in Intoxications Maria Ferris, MD, MPH, PhD University of North Carolina Kidney Center Chapel Hill, North Carolina USA 7/17/2015.
Tomáš Zaoral1, Michal Hladík1, Jana Zapletalová2 1Pediatric intensive care unit, Department of Pediatrics,Faculty of Medicine, University Hospital Ostrava.
DIALYSIS SOLUTIONS INC.
Pediatric CRRT Programs: A tool-kit for evaluation Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
David Askenazi MD, MSPH Associate Professor of Pediatrics 2Smaller Circuits for Smaller Patients Improving Renal Support with Aquadex™ Machine.
Brophy University of Iowa Pediatric CRRT Anticoagulation Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital PCRRT.
Citrate Anticoagulation
Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.
Vascular Access Considerations and Options for Pediatric CRRT Stuart L. Goldstein, MD.
Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan.
PCRRT Multi-Center Registry Data Effective April 1, 2002 Multi-Center Pediatric CRRT Registry Stuart L. Goldstein, MD Assistant Professor of Pediatrics.
Vascular Access in CRRT Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Chapter 26. Dialysis PD vs HD 300,000 patients in the US on HD Destination therapy for most patients Increasing rates of DM and HTN in the US Upper extremity.
PCRRT Tûr'mə-nŏl'ə-jē Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Continuous Renal Replacement Therapy Developed by: Critical Care and Hemodialysis Educators, February 2009 King Faisal Specialist Hospital and Research.
Vascular Access The Alpha and Omega of CRRT Rick Hackbarth MD Division of Pediatric Critical Care Grand Rapids, Michigan.
Renal Replacement Therapy in the CICU Stuart L. Goldstein, MD Professor of Pediatrics University or Cincinnati College of Medicine Director, Center for.
신장내과 R4 김효식 /Prof. 전진석 혈액투석의 시작. Dialysis start Patients with eGFR >15 mL/min/1.73 m 2 Generally do not initiate chronic dialysis for such patients, ev.
World Kidney Day 2016: Kidney Disease & Children
CONTINUOUS RENAL REPLACEMENT THERAPY
Continuous renal replacement therapy
Access for Pediatric CRRT
Spotlight on general principles of hemodialysis
Devices use for Neonatal AKI
DEBATE: Timing of CRRT in Critical Care
Etiology of Acute Kidney Injury in Neonates
Outcomes of Acute Kidney Injury in Neonates
Pediatric Central Venous Catheters In Patients Less Than Two Years Of Age: Do Complication Rates Differ Between Tunneled IJ, Tunneled Femoral, and PICCs?
Feeding Modality is a Barrier to Providing Adequate Protein to Pediatric Patients Receiving Continuous Renal Replacement Therapy Molly Wong Vega, MS, RDN.
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Pediatric CRRT Terminology
Access in Pediatric CRRT
Basics of CRRT: Terminology
SCUF Slow Continuous Ultrafiltration
Children’s Memorial Hospital Northwestern University
Plasmapheresis With (and Without) CRRT
Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.
Presentation transcript:

Vascular Access and Infused Fluids for Pediatric CRRT 9th International pCRRT Conference on Pediatric Continuous Renal Replacement Therapy August 31-September 2, 2017 Vascular Access and Infused Fluids for Pediatric CRRT Jordan M Symons, MD Seattle Children’s Hospital University of Washington School of Medicine

Continuous Renal Replacement Therapy (CRRT) What does it take to make this work? Vascular access Infused fluids Rinse-O-Matic 3000

Vascular Access for Pediatric CRRT

Vascular Access for Pediatric CRRT: Starting Points Functional access is crucial for therapy Poor access = clotted circuits = lost Rx Achieving vascular access may be challenging Especially in smaller children “If you don’t have an access, you may as well go home”

Vascular Access for Pediatric CRRT: What Will Work? Usually HD catheter Temporary vs tunneled? Low resistance preferred Poiseuille’s law: R = 8hL/pr4 Therefore: Fat, short catheter would be best Caveats Longer catheter may reach larger vessel Fatter catheter is harder to place

Pediatric CRRT: Access Options Patient Size Catheter Size Neonates 7 Fr 3 – 6 Kg 6 – 12 Kg 8 Fr 12 – 20 Kg 9 Fr 20 – 30 Kg 10 Fr > 30 Kg 10 – 12 Fr Adapted from Cincinnati Children’s Hospital Center for Acute Care Nephrology Acute Dialysis/CRRT/Pheresis Access Guideline

Pediatric CRRT: Access Location Internal Jugular Very accessible Large caliber (SVC) Great flows Low recirculation rate Risk for Pneumothorax Cardiac monitoring may take precedence Femoral Usually accessible Smaller than SVC Flow hampered by: Abdominal pressure Patient movement Risk for retroperitoneal hemorrhage Higher recirculation rate Subclavian A suboptimal choice

Circuit Survival by Catheter Size Hackbarth R., et al. Int J Artif Organs. 2007 Dec;30(12):1116-21.

Circuit Survival by Catheter Location IJ Femoral SC 5Fr Demise! Hackbarth R., et al. Int J Artif Organs. 2007 Dec;30(12):1116-21.

Vascular Access Issues Long skinny catheters don’t flow well Umbilical lines are a poor choice “Dialysis-grade” catheters necessary Stiffer; won’t collapse Newer CRRT devices Options for neonates? Tunneled or temporary? Mobility Infection risk Performance Patient stability Speed/ease of access If starting with temp cath, consider when to change Important to communicate with those who place the access!

Infused Fluids for Pediatric CRRT

Purpose of CRRT solutions Provide safe and consistent metabolic control To be adaptive to the choice of therapy Convection Diffusion Combination

Diffusion

Convection

Clearance: Convection vs. Diffusion

Modality May Have an Impact on Choice of Solutions Diffusion requires the use of a dialysate Convection requires the use of replacement fluids R R D

What’s the Difference Between Dialysate and Replacement Fluid? Dialysate is a Device Replacement Fluid is a Drug

Options for CRRT Solutions Peritoneal dialysate: Pre-made IV solutions: Saline, Lactated Ringers Custom-made solutions: On-line generation: Commercially available CRRT solutions ANCIENT HISTORY MAYBE? RARELY DEVICE-DEPENDENT

Characteristics of the Ideal CRRT Solution Physiological Reliable Inexpensive Easy to prepare Simple to store Quick to the bedside Widely available Fully compatible Numerous solutions from multiple vendors available

Rate for Infused Fluid Higher rates increase clearance Lower rates may simplify electrolyte balance and limit losses Equations to help choose rate for fluid: 20-60 ml/kg/hr 2000 – 3000 ml/hr/1.73m2 May need higher rates to balance citrate delivery

Convection Favors Loss of Larger Molecules Consider your overall clinical goals when choosing solutions and modalities Small molecules and drugs Middle molecules and drugs Larger molecules and drugs Very large molecules and drugs

Issues with the Biochemical Profile of Infused CRRT Fluids Patient’s blood chemistry approaches that of infused fluids Errors in fluid content (mixing or inappropriate choice for situation) can lead to significant abnormalities x

Vascular Access and Infused Fluids for Pediatric CRRT Commercial solutions are a standard part of the modern CRRT prescription Allow improved clearance Need consideration to achieve balance Thoughtful hemocatheter selection and placement will permit effective therapy “It all starts with the access!”

Thanks! “Pull out, Betty! Pull out! . . . You’ve hit an artery!”